Company / Interest Expense per Share
Ernexa Therapeutics Inc. Interest Expense per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.05
FY2025
5-year range
$0.01 / $0.10
FY2021-FY2025
Trend
+56.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2014 to $0.17 in FY2018.
Based on SEC 10-K filings.
0.05 in FY2025 with a 10-year CAGR of +36.4%.
Increased from $0.01 to $0.05 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -9.0%
- 10-Year CAGR
- +36.4%
Key checks
Key Insights
- In FY2025, interest expense per share increased 56.1% year-over-year.
- Peak interest expense per share was recorded in FY2018.
- Lowest interest expense per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | +56.1% |
| FY2024 | $0.03 | +456.0% |
| FY2023 | $0.01 | -92.8% |
| FY2020 | $0.08 | -21.0% |
| FY2019 | $0.10 | -38.9% |
| FY2018 | $0.17 | +2914.3% |
| FY2017 | $0.01 | -96.3% |
| FY2016 | $0.15 | +6632.3% |
| FY2015 | $0.00 | +587.7% |
| FY2014 | $0.00 | -46.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026